North America Pharmaceutical Contract Sales Organizations Market
The North America Pharmaceutical Contract Sales Organizations Market size was valued at US$ 3,987.29 Mn in 2022 and is projected to reach US$ 7,614.12 Mn by 2030, growing at a CAGR of 8.4% during 2022 - 2030.
Report Coverage
- Services: Commercial Services, Non-Commercial Services
- Modules: Syndicated Modules, Dedicated Modules
- Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases
- End User: Biopharmaceutical Companies, Pharmaceutical Companies
US$ 3,987.29 Mn
Market size in 2022
US$ 7,614.12 Mn
Market Size by 2030
8.4%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Pharmaceutical Contract Sales Organizations Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Pharmaceutical Contract Sales Organizations Market Regional Analysis
6.2 North America Pharmaceutical Contract Sales Organizations Market Revenue 2020-2030 (US$ Million)
6.3 North America Pharmaceutical Contract Sales Organizations Market Forecast Analysis
7. North America Pharmaceutical Contract Sales Organizations Market Analysis – by Services
7.1 Commercial Services
- 7.1.1 Overview
- 7.1.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Non-Commercial Services
- 7.2.1 Overview
- 7.2.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Pharmaceutical Contract Sales Organizations Market Analysis – by Modules
8.1 Syndicated Modules
- 8.1.1 Overview
- 8.1.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Dedicated Modules
- 8.2.1 Overview
- 8.2.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Pharmaceutical Contract Sales Organizations Market Analysis – by Therapeutic Area
9.1 Cardiovascular Disorders
- 9.1.1 Overview
- 9.1.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Oncology
- 9.2.1 Overview
- 9.2.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Metabolic Disorders
- 9.3.1 Overview
- 9.3.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Neurology
- 9.4.1 Overview
- 9.4.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Orthopedic Diseases
- 9.5.1 Overview
- 9.5.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Infectious Diseases
- 9.6.1 Overview
- 9.6.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Pharmaceutical Contract Sales Organizations Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Pharmaceutical Companies
- 10.2.1 Overview
- 10.2.2 Pharmaceutical Companies : North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. North America Pharmaceutical Contract Sales Organizations Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 US: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.1.2 US: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.1.3 US: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.1.4 US: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.2 Canada: North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.2.2 Canada: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.2.3 Canada: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.2.4 Canada: North America Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.3 Mexico : North America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Mexico : North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.3.2 Mexico : North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.3.3 Mexico : North America Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.3.4 Mexico : North America Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Aenova Holding GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Axxelus Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 CMIC Holdings Co Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 IQVIA Holdings Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Peak Pharma Solutions Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Pfizer Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Promoveo Health LLC
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 QFR Solutions LLC
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Sales Focus Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Syneos Health Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.